0000950170-24-035358.txt : 20240322 0000950170-24-035358.hdr.sgml : 20240322 20240322161223 ACCESSION NUMBER: 0000950170-24-035358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240320 FILED AS OF DATE: 20240322 DATE AS OF CHANGE: 20240322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIGGS RORY B CENTRAL INDEX KEY: 0001016835 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 24775339 MAIL ADDRESS: STREET 1: 65 RAILROAD AVE CITY: RIDGEFIELD STATE: NJ ZIP: 07657 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 4 1 ownership.xml 4 X0508 4 2024-03-20 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001016835 RIGGS RORY B C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016 true false false false false Common Stock 2024-03-20 4 M false 20000 18.56 A 99235 D Stock Option (right to buy) 18.56 2024-03-20 4 M false 20000 0 D 2024-03-21 Common Stock 20000 0 D On March 20, 2024, the reporting person exercised options to purchase 20,000 shares of common stock that were expiring on March 21, 2024. On March 21, 2014, the reporting person was granted options to purchase 20,000 shares of common stock, vesting as to 50% of the shares on January 8, 2015 and as to the remainder of the shares on January 8, 2016. /s/ Lawrence J. Hineline, Attorney-in-fact 2024-03-22